Skip to content

Medtronic MDT EV / EBITDA

EV / EBITDA at other companies

Abbott logo
AbbottABT
18.9×-4.1×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
12.3×-6.5×
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×
Stryker logo
StrykerSYK
22.1×-11.8×
Boston Scientific logo
Boston ScientificBSX
28.3×-8.5×
Intuitive Surgical logo
Intuitive SurgicalISRG
77.8×+12.8×

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$100.32B-3.8%
Enterprise value$127.58B-3.2%
P/E20.9×-1.5×
P/S2.8×-0.4×

Profitability

See full
Gross margin64.9%-0.3pp
Operating margin17%0.0pp
Net margin13%-0.7pp

Returns & leverage

See full
Return on equity9.4%+0.3pp
Debt / equity0.6×0.0×
Current ratio2.5×+0.3×

Where this comes from

Calculated from Medtronic’s reported figures.

Based on the most recent quarter.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's EV / EBITDA?
Medtronic (MDT) reported EV / EBITDA of 13.9× in Q1 2026.
How has Medtronic's EV / EBITDA changed year-over-year?
Medtronic's EV / EBITDA decreased by 9.5% year-over-year, from 15.4× to 13.9×.
What is the long-term trend for Medtronic's EV / EBITDA?
Over 5 years (2021 to 2026), Medtronic's EV / EBITDA has grown at a -10.3% compound annual growth rate (CAGR), from 108.1× to 62.8×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.